AFFX on NASDAQ

Affymetrix

Logo: Affymetrix, Public domain, via Wikimedia Commons5

American biotech company

Affymetrix is now Applied Biosystems, a brand of DNA microarray products sold by Thermo Fisher Scientific that originated with an American biotechnology research and development and manufacturing company of the same name. The Santa Clara, California-based Affymetrix, Inc. now a part of Thermo Fisher Scientific was co-founded by Alex Zaffaroni and Stephen Fodor. Stephen Fodor and his group, based on their earlier development of methods to fabricate DNA microarrays using semiconductor manufacturing techniques.3 It is part of Thermo Fisher Scientific Inc.1 Its shares trade on NASDAQ under the symbol AFFX.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

1992Founded1

Compare with another stock.

  • TickerAFFX on NASDAQ1
  • Industrybiotechnology1
  • HeadquartersSanta Clara1
  • Websitewww.affymetrix.com
  • Legal formDelaware corporation1
  • Incorporated inDE6
  • Business address3420 Central Expressway, Santa Clara, Ca 950516
  • Filer categoryLarge accelerated filer6
  • LEIZZBUNDSZ6C10YEZJCR944
  • StatusActive4
  • LEI statusLapsed (not renewed)4
  • Registered addressC/O Corporation Service Company, 19808 Wilmington, United States4
  • Registered withDivision of Corporations, Department of State, 28725454

Affymetrix is now Applied Biosystems, a brand of DNA microarray products sold by Thermo Fisher Scientific that originated with an American biotechnology research and development and manufacturing company of the same name. The Santa Clara, California-based Affymetrix, Inc. now a part of Thermo Fisher Scientific was co-founded by Alex Zaffaroni and Stephen Fodor. Stephen Fodor and his group, based on their earlier development of methods to fabricate DNA microarrays using semiconductor manufacturing techniques.3

Corporate structure

Affymetrix is part of a group headed by Thermo Fisher Scientific Inc.. 1,172 entities, 39 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0). Each entity in the chart links to its source.

What it owns

What Affymetrix reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$181.9M8 Dec 31, 2015$177.0M8 Dec 31, 2014+2.8%
Accumulated depreciation$160.9M8 Dec 31, 2015$158.9M8 Dec 31, 2014+1.2%
Property and equipment, net$21.0M8 Dec 31, 2015$18.1M8 Dec 31, 2014+16.1%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$88.8M8 Dec 31, 2015$79.9M8 Dec 31, 2014+11.1%
Marketable securities, current$30.0M8 Dec 31, 2015$08 Dec 31, 2014

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$154.5M8 Dec 31, 2015$156.2M8 Dec 31, 2014−1.0%
Intangible assets, net (excluding goodwill)$102.4M8 Dec 31, 2015$106.2M8 Dec 31, 2014−3.6%
Accumulated amortization$160.1M8 Dec 31, 2015$146.8M8 Dec 31, 2014+9.1%
Finite-lived intangibles, net$90.4M8 Dec 31, 2015$106.2M8 Dec 31, 2014−14.9%

Inventory

ItemLatestA year beforeChange
Inventory, total$54.1M8 Dec 31, 2015$50.7M8 Dec 31, 2014+6.8%
Work in process$17.8M8 Dec 31, 2015$18.1M8 Dec 31, 2014−2.2%
Finished goods$28.1M8 Dec 31, 2015$27.0M8 Dec 31, 2014+3.8%

The story

Founded by Stephen Fodor in 1992.1

Affymetrix, Inc. was spun-off from Affymax Research Institute by Alex Zaffaroni in 1993, and was eventually based in Santa Clara, California, United States. It began as a unit in Affymax N.V. in 1991 under Fodor and his group. In the late 1980s, that group had developed methods for fabricating DNA microarrays, under the "GeneChip" Affymetrix trademark, using semiconductor manufacturing techniques. The company's first product, an HIV genotyping GeneChip, was introduced in 1994 and the company went public in 1996.

From Wikipedia’s article on Affymetrix, shared under CC BY-SA 4.0.7

Leadership

Who has led Affymetrix, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (23)

Subsidiaries and ownership

Parent company

From Wikidata.1

Acquisitions

Prior to its acquisition by Thermo Fisher, and its becoming a line of its products, Affymetrix, Inc. had acquired the technologies of a number of companies. It acquired Genetic MicroSystems for slide-based microarrays and scanners and Neomorphic for bioinformatics, both in 2000, ParAllele Bioscience for custom SNP genotyping, USB/Anatrace for biochemical reagents in 2008, eBioscience for flow cytometry in 2012, and Panomics in 2008 and True Materials to expand its offering of low to mid-plex applications. In 2000, Perlegen Sciences spun out from Affymetrix to focus on wafer-scale genomics for massive data creation and collection required for characterizing population variance of genomic markers and expression for the drug discovery process.

From Wikipedia’s article on Affymetrix, shared under CC BY-SA 4.0.7

Timeline

  1. Jul 7, 2011New chief executive Frank Witney becomes CEO9
  2. Jan 6, 2009New chief executive Kevin M. King becomes CEO10
  3. May 31, 2006New chief executive Stephen Fodor becomes CEO11
  4. 1992Founded Founded1

SEC filer profile

How Affymetrix is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARAFFYMETRIX INC2
  • CIK0000913077
  • Employer ID (EIN)77-03191592
  • Filer statusLarge accelerated filer2
  • Incorporated inDelaware2
  • Fiscal year endsDecember 312
  • Industry code (SIC)3826 Laboratory Analytical Instruments2
  • Business address3420 Central Expressway, Santa Clara, CA 950512
  • Phone40873150002
  • Shares outstanding80,541,254 as of Feb 11, 20168
  • Public float$865.0M as of Jun 30, 20158
  • On EDGAR sinceMay 20, 19962
  • Filings1,189 in all: 4 (502), 8-K (184), SC 13G/A (106), 10-Q (59), SC 13G (50), DEFA14A (41), 424B3 (34), 3 (19)2
    All 53 form types

    DEF 14A (19), S-8 POS (16), 10-K (14), S-8 (14), S-3/A (8), UPLOAD (8), POS AM (7), S-3 (7), 10-K405 (6), 8-K/A (6), EFFECT (6), SC TO-I/A (6), 4/A (5), 425 (5), CORRESP (5), S-4/A (5), SC 13D/A (5), 10-K/A (4), 424B5 (4), ARS (4), 10-Q/A (3), PRE 14A (3), SC 13D (3), 15-15D (2), 424B1 (2), 5 (2), DFAN14A (2), FWP (2), S-1/A (2), S-4 (2), SC TO-I (2), SD (2), 15-12G (1), 25-NSE (1), 8-A12G (1), 8-A12G/A (1), DEFM14A (1), DEFR14A (1), NT 10-Q (1), POSASR (1), PREM14A (1), PRER14A (1), RW (1), S-3ASR (1), SC TO-C (1)

  • Latest filingsAnnual report (10-K) Feb 18, 2016
    Quarterly report (10-Q) Oct 29, 2015
    Proxy statement (DEF 14A) Mar 31, 2015
    Latest 8-K (8-K) Mar 31, 2016

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38